We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pfizer won a preliminary victory in its fight to retain patent protection on
its blood pressure medication Accupril when a federal district court issued
a preliminary injunction blocking generic firms Teva Pharmaceutical and Ranbaxy
Pharmaceuticals from selling a generic version of the drug.
Although shifting some Medicare Part B drugs to Part D could stoke competitive
pressures on pharmaceutical pricing, the HHS does not recommend consolidating
the coverage until the Medicare prescription drug benefit has had a chance to
get up and running, according to a new report.
Elite Pharmaceuticals, Inc. announced the entry into an agreement with a specialty
dermatological marketing company, and a boutique formulation development company,
for the manufacture and distribution of a controlled release drug product.
Perlegen Sciences said it received a biodefense partnership grant award from
the National Institute of Allergy and Infectious Diseases to analyze the genomes
the bacteria that causes plague.
CoTherix announced a collaborative research and development agreement with Quadrant
Drug Delivery, Limited to develop an extended-release formulation of CoTherix's
product, Ventavis (iloprost) Inhalation Solution.
Biotech company Avigen said Tuesday that it will focus on developing more traditional
pharmaceuticals as it discontinues funding for technology that uses viruses
as a drug delivery vehicle.
4SC AG, a drug discovery and development company specializing in research and
development of therapeutic agents, announced that they have made a research
cooperation agreement with SCHWARZ PHARMA AG, Monheim.
Generic drugmaker Hi-Tech Pharmacal said it signed a licensing and supply agreement
regarding a generic version of BioMarin Pharmaceutical Inc.'s Orapred medication.
Johnson & Johnson announced that it has completed
its acquisition of TransForm Pharmaceuticals, Inc., a Lexington, Mass.-based
company specializing in the discovery of superior formulations and novel crystalline
forms of drug molecules.